{
  "main_header": {
    "sid": 1002925,
    "name": "Medico Remedies",
    "stock_name": "Medico Remedies",
    "full_name": "Medico Remedies Ltd",
    "name_url": "stocks-analysis/medico-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "42.86",
    "chg": 0.34,
    "chgp": "0.8%",
    "dir": 1,
    "prev_price": "42.52",
    "mcapval": "355.67 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540937,
    "symbol": "MEDICO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE630Y01024",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "2.25 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medico Remedies Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-by-marketsmojo-4002691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicoRemediesL_mojoScore_4002691.png",
        "date": "2026-05-21 10:10:58",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Medico Remedies Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-by-marketsmojo-3983935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicoRemediesL_mojoScore_3983935.png",
        "date": "2026-05-10 10:10:37",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Medico Remedies Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-3944503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicoRemediesL_mojoScore_3944503.png",
        "date": "2026-04-13 10:10:45",
        "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Medico Remedies Downgraded to Sell Amid Mixed Financials and Valuation Shift",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-downgraded-to-sell-amid-mixed-financials-and-valuation-shift-3929697",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicoRemediesL_mojoScore_3929697.png",
        "date": "2026-04-02 08:32:29",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell despite an upgrade in its valuation grade from fair to attractive. This shift, effective from 1 April 2026, reflects a complex interplay of factors including valuation metrics, financial trends, quality assessments, and technical indicators, which together paint a nuanced picture for investors."
      },
      {
        "title": "Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-3923375",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_valuationdot_3923375.png",
        "date": "2026-03-30 08:01:50",
        "description": "Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, reflecting a more compelling price proposition for investors. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest improved relative value compared to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Medico Remedies Ltd Falls to 52-Week Low of Rs 33.78 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-falls-to-52-week-low-amid-continued-market-pressure-3919997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_priceRelatedfactors_3919997.png",
        "date": "2026-03-27 14:46:03",
        "description": "A sharp decline in Medico Remedies Ltd has pushed the stock to a fresh 52-week low of Rs 33.78 on 27 Mar 2026, marking a significant 6.22% intraday drop amid broader market weakness. This latest fall extends the stock’s losing streak to two consecutive sessions, reflecting persistent selling pressure despite the company’s recent positive financial results."
      },
      {
        "title": "Medico Remedies Falls 3.91%: Death Cross and Downgrade Signal Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-falls-391-death-cross-and-downgrade-signal-bearish-momentum-3905180",
        "imagepath": "",
        "date": "2026-03-21 13:02:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Stock opens at Rs.39.18, down 1.11% amid Sensex gains</p>\n                    <p><strong>18 Mar:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>19 Mar:</strong> Downgrade to 'Sell' rating amid technical weakness</p>\n                    <p><strong>20 Mar:</strong> Slight recovery to Rs.38.07, but weekly loss persists</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.39.62</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">R..."
      }
    ],
    "total": 15,
    "sid": "1002925",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/medico-remedies-1002925"
  },
  "announcements": [
    {
      "caption": "Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "03-Jun-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today",
      "datetime": "21-May-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 21st May 2026 has inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the quarter ended 31st March 2026 and Audited Financial Statements for the year ended on 31st March 2026 along with the Auditors Report thereon. We would like to state that M/s. Shah Shroff & Associates Statutory Auditors of the Company have issued audit report with unmodified opinion on the Statements. 2. Boards Report and its annexures Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March 2026. We wish to inform you that the Board Meeting commenced today at 5:00 P.M and concluded at 5:25 P.M.",
      "source": "BSE"
    },
    {
      "caption": "Audited Standalone Financial Results Of The Company For The Quarter Ended 31St March 2026 And Audited Financial Statements For The Year Ended On 31St March 2026 Along With The AuditorS Report Thereon",
      "datetime": "21-May-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23",
          "dt": "2023-03-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21",
          "dt": "2021-11-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medico Remedies Ltd is Rated Hold by MarketsMOJO

2026-05-21 10:10:58

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read More

Medico Remedies Ltd is Rated Hold by MarketsMOJO

2026-05-10 10:10:37

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read More

Medico Remedies Ltd is Rated Sell

2026-04-13 10:10:45

Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read More

Medico Remedies Downgraded to Sell Amid Mixed Financials and Valuation Shift

2026-04-02 08:32:29

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell despite an upgrade in its valuation grade from fair to attractive. This shift, effective from 1 April 2026, reflects a complex interplay of factors including valuation metrics, financial trends, quality assessments, and technical indicators, which together paint a nuanced picture for investors.

Read More

Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-30 08:01:50

Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, reflecting a more compelling price proposition for investors. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest improved relative value compared to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read More

Medico Remedies Ltd Falls to 52-Week Low of Rs 33.78 as Sell-Off Deepens

2026-03-27 14:46:03

A sharp decline in Medico Remedies Ltd has pushed the stock to a fresh 52-week low of Rs 33.78 on 27 Mar 2026, marking a significant 6.22% intraday drop amid broader market weakness. This latest fall extends the stock’s losing streak to two consecutive sessions, reflecting persistent selling pressure despite the company’s recent positive financial results.

Read More

Medico Remedies Falls 3.91%: Death Cross and Downgrade Signal Bearish Momentum

2026-03-21 13:02:24

Key Events This Week 16 Mar: Stock opens at Rs.39.18, down 1.11% amid Sensex gains 18 Mar: Death Cross formation signals potential bearish trend 19 Mar: Downgrade to 'Sell' rating amid technical weakness 20 Mar: Slight recovery to Rs.38.07, but weekly loss persists Week OpenRs.39.62 Week CloseR...

Read More

View All News